Catching a scatter of small pale dots across your cheekbones after months of gentle, comfortable laser sessions is nobody’s reason for booking. It is, though, a documented complication of one of the most heavily promoted pigmentation treatments in the region, and the sessions that cause it are usually the ones that felt like they were doing nothing at all.
Searches for Pico laser in Singapore and related terms have grown quickly, and most of what a patient reads focuses on downtime and comfort. The evidence on repeated low-fluence treatment tells a more complicated story, and understanding it is what allows a sensible decision about whether a laser belongs in a pigmentation plan at all.
What laser toning refers to
Laser toning describes a protocol rather than a machine. A Q-switched 1,064 nm neodymium-doped yttrium aluminium garnet laser, usually shortened to Nd:YAG, is delivered at low energy with a large spot size over multiple passes, then repeated frequently, often weekly or fortnightly for many sessions. The appeal is obvious. Each session is nearly painless, there is little visible redness, and the skin looks slightly brighter afterwards.
That gentleness is also what allows the treatment to accumulate. Because no single session produces a reaction worth noticing, there is nothing to signal when enough has become too much.
How pigment gets lost rather than lightened
Melanin sits inside pigment-producing cells called melanocytes, which pass it to the surrounding skin cells. Repeated low-energy pulses damage those cells cumulatively instead of clearing pigment cleanly. In three patients treated at a Singapore centre, biopsies of the pale areas showed reduced melanocyte numbers and shortened cellular processes compared with adjacent normally pigmented skin1. The pigment had not been dispersed. The cells that make it had gone.
The clinical result is described as guttate or mottled hypomelanosis, a scatter of small pale macules that becomes conspicuous against surrounding skin, and it does not reliably repigment. In one Thai trial of five weekly sessions for facial melasma, mottled hypopigmentation occurred in 3 of 22 patients and rebound hyperpigmentation in 4 of 222.
In a larger Japanese series of 147 patients treated with laser toning, overall leukoderma incidence was 2%, and ultraviolet photography detected early change eight to nine sessions before it became clinically visible3. Patients in that series had received treatment at weekly, fortnightly and monthly intervals, and spacing sessions further apart did not significantly change the risk.
That last finding is the uncomfortable one. By the time a patient or a clinician can see the problem, it has been developing for months.
Rebound, recurrence and the melasma problem
Melasma is the indication laser toning is most often sold for, and it is also the one where the evidence is weakest. In the Thai trial, melasma recurred in all 22 patients, and the authors concluded the protocol produced only temporary improvement alongside those side effects2.
A consensus review by an expert pigmentary group reached the same practical conclusion, stating that laser cannot be the first-line treatment for melasma and serves at most as a supplementary approach in resistant cases with careful patient selection and counselling4. Topical treatment, trigger control and disciplined photoprotection remain the foundation, which is not a fashionable message but is the one the literature supports.
Singapore makes the photoprotection point harder to ignore. Sitting close to the equator, the country records high ultraviolet readings through the year. Any pigmentation plan that ignores daily sun exposure is working against itself.
The risk that runs in the opposite direction
Hypopigmentation is not the only hazard. Post-inflammatory hyperpigmentation, where treated skin darkens instead of clearing, is well documented in Asian skin and is directly relevant to Fitzpatrick skin types III to V. In a study of non-ablative fractional resurfacing in Asian patients, generalised post-inflammatory hyperpigmentation occurred in 7.1% with high-energy, low-density settings and 12.4% with low-energy, high-density settings, and the authors concluded that adequate parameter selection can significantly reduce the risk in darker skin5.
Post-inflammatory hyperpigmentation behaves differently from melasma and needs a different plan, which is one reason a diagnosis should precede any device decision.
What a more careful approach involves
None of this makes pigment lasers unsuitable. Picosecond devices have reasonable published support in Asian skin for certain dermal pigmentary conditions, with one Singapore review of 29 patients with Fitzpatrick skin types III and IV reporting improvement in naevus of Ota and Hori’s naevus alongside transient hypopigmentation in a single patient6. Those are dermal conditions and not melasma, and the distinction is the whole argument.
The practical safeguards are unglamorous. A diagnosis before a device. A test patch. Fewer sessions at appropriate settings instead of many at low ones. A defined review point at which treatment stops if the skin is not responding. Photography under consistent lighting so gradual change is caught early. A clinician who declines to treat is often reading the skin correctly.
Skin phototype belongs in that conversation from the outset. Fitzpatrick types III to V carry a higher risk of both pigment loss and post-inflammatory darkening than lighter skin, and a protocol borrowed from a European or American clinic will not automatically transfer. Any candid discussion should also cover what happens if the result is unsatisfactory, since correcting hypopigmentation is considerably more difficult than treating the pigmentation that prompted the first appointment.
Conclusion
Pigment that has been lost is considerably harder to restore than pigment that needs fading, which is the whole case for caution. At Angeline Yong Dermatology, Dr Angeline Yong assesses the type and depth of pigmentation, skin phototype, and treatment history before recommending any device or topical approach, drawing on a wide range of options available at the clinic. Book a consultation to discuss what suits your skin and what should be left alone.
References
Wong, Y., Lee, S. S. J., & Goh, C. L. (2015). Hypopigmentation induced by frequent low-fluence, large-spot-size QS Nd:YAG laser treatments. Annals of Dermatology, 27(6), 751. https://doi.org/10.5021/ad.2015.27.6.751
Wattanakrai, P., Mornchan, R., & Eimpunth, S. (2010). Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatologic Surgery, 36(1), 76–87. https://doi.org/10.1111/j.1524-4725.2009.01383.x
Sugawara, J., Kou, S., Kou, S., Yasumura, K., Satake, T., & Maegawa, J. (2015). Influence of the frequency of laser toning for melasma on occurrence of leukoderma and its early detection by ultraviolet imaging. Lasers in Surgery and Medicine, 47(2), 161–167. https://doi.org/10.1002/lsm.22325
Sarkar, R., Aurangabadkar, S., Salim, T., Das, A., Shah, S., Majid, I., Singh, M., Ravichandran, G., Godse, K., Arsiwala, S., Arya, L., Gokhale, N., Sarma, N., Torsekar, R. G., Sonthalia, S., & Somani, V. K. (2017). Lasers in melasma: A review with consensus recommendations by Indian pigmentary expert group. Indian Journal of Dermatology, 62(6), 477. https://doi.org/10.4103/ijd.IJD_488_17
Chan, H. H. L., Manstein, D., Yu, C. S., Shek, S., Kono, T., & Wei, W. I. (2007). The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers in Surgery and Medicine, 39(5), 381–385. https://doi.org/10.1002/lsm.20512
Koh, Y. P., Tan, A. W. M., & Chua, S. H. (2020). Treatment of laser-responsive dermal pigmentary conditions in type III-IV Asian skin with a 755-nm picosecond pulse duration laser: A retrospective review of its efficacy and safety. Dermatologic Surgery, 46(11), e82–e87. https://doi.org/10.1097/DSS.0000000000002332